Immunotherapy with fragmented Mycobacterium tuberculosis cells increases the effectiveness of chemotherapy against a chronical infection in a murine model of tuberculosis.
about
Immunotherapy for tuberculosis: future prospectsRecent advances in the development of vaccines for tuberculosisPrime-boost approaches to tuberculosis vaccine developmentImmunogenicity without Efficacy of an Adenoviral Tuberculosis Vaccine in a Stringent Mouse Model for Immunotherapy during TreatmentThe Progress of Therapeutic Vaccination with Regard to TuberculosisAdjunct Strategies for Tuberculosis Vaccines: Modulating Key Immune Cell Regulatory Mechanisms to Potentiate VaccinationProphylactic effect of a therapeutic vaccine against TB based on fragments of Mycobacterium tuberculosisGranuloma encapsulation is a key factor for containing tuberculosis infection in minipigsThe scavenger protein apoptosis inhibitor of macrophages (AIM) potentiates the antimicrobial response against Mycobacterium tuberculosis by enhancing autophagy.The immunology of tuberculosis: from bench to bedside.Subunit vaccine consisting of multi-stage antigens has high protective efficacy against Mycobacterium tuberculosis infection in mice.Effectiveness of tuberculosis chemotherapy correlates with resistance to Mycobacterium tuberculosis infection in animal modelsESAT-6 (EsxA) and TB10.4 (EsxH) based vaccines for pre- and post-exposure tuberculosis vaccination.Immunotherapeutic role of Ag85B as an adjunct to antituberculous chemotherapyDrug treatment combined with BCG vaccination reduces disease reactivation in guinea pigs infected with Mycobacterium tuberculosis.Tuberculosis vaccines: current status and future prospects.CBA/J mice generate protective immunity to soluble Ag85 but fail to respond efficiently to Ag85 during natural Mycobacterium tuberculosis infection.Immunological options for the treatment of tuberculosis: evaluation of novel therapeutic approaches.Induction of a specific strong polyantigenic cellular immune response after short-term chemotherapy controls bacillary reactivation in murine and guinea pig experimental models of tuberculosis.Therapeutic vaccination to treat chronic infectious diseases: current clinical developments using MVA-based vaccines.Therapeutic immunization against Mycobacterium tuberculosis is an effective adjunct to antibiotic treatment.Enhanced gamma interferon responses of mouse spleen cells following immunotherapy for tuberculosis relapse.Antituberculous vaccine development: a perspective for the endemic world.Tuberculosis vaccines: present and future.Immunotherapy for TB.Global Efforts in the Development of Vaccines for Tuberculosis: Requirements for Improved Vaccines Against Mycobacterium tuberculosis.Adjunct immunotherapy with Ag85 complex proteins based subunit vaccine in a murine model of Mycobacterium tuberculosis infection.TBVAC2020: Advancing Tuberculosis Vaccines from Discovery to Clinical DevelopmentThe tuberculin skin test increases the responses measured by T cell interferon-gamma release assays.A Multi-Compartment Hybrid Computational Model Predicts Key Roles for Dendritic Cells in Tuberculosis Infection.A multi-antigenic MVA vaccine increases efficacy of combination chemotherapy against Mycobacterium tuberculosis.How could we have better vaccines against tuberculosis?Live tuberculosis vaccines based onphoPmutants: a step towards clinical trials
P2860
Q26741261-0341096E-12CB-4E1C-9908-A4371540EC97Q26796440-91D15367-5C52-475C-B8F1-F01FA488E2CDQ27024526-2AD05575-8420-451C-8F65-D660090DE469Q27306144-0C54DD6B-522D-4862-86BD-D77414E220A8Q28072271-0A55D62C-57D2-44D1-9891-2F946127D9BFQ28074536-D7CEA167-EB0C-439E-9DBB-C3D2D27E0342Q28744312-16834B74-B2E8-4B55-A0D6-5BEF234ED32EQ28748169-26AD2FC9-A343-46EA-9155-EC52CF1D52F1Q31143734-586E5F18-0965-4BA7-AC9A-5195CD406A13Q33777367-E7000570-A529-4308-9BB8-457A2F856DFFQ34965575-46574743-BCDE-42EE-BAD2-D8FCF6643838Q35037392-A99E0972-9A58-48BE-97BD-2D776B2D72D3Q35069386-36F6184B-96A3-438F-B81C-E0593A558769Q35124651-9679288C-A064-4BDB-94A7-607228C40E76Q35778099-53597D0F-33A9-40C0-9B64-38BBD1CDC9FFQ36458393-090C4706-D567-4C02-A7E5-9DB65275718BQ36811028-3BA5D836-C51C-4BA3-B600-13D429B4A934Q36839739-9423E8C9-69E8-4360-AB79-97EF7539D006Q36844900-9E7BEE6B-BC05-40C3-84AF-9FBACFEB8FB7Q36849770-4B9E50A8-319C-488C-8E80-58394C2E3B25Q36957252-C8D40CCB-230F-4D38-937E-6AD96D8A6712Q36974318-67CFEE22-BEB1-4F25-8869-FF88EF8D028BQ37622900-34176011-8224-4EC3-BDB3-A596544D6912Q37754908-8A6FC9CB-EE18-4BD0-A17A-3E22C06C7836Q38025666-6F459592-E8EC-4E36-8F49-0A4872866742Q38907507-7D7BD18D-DDA5-491C-AE3A-53EE55480184Q40014676-4530E4BC-AB2E-4055-81C6-181BE0BE079DQ42372774-A8495278-E840-4CBA-A484-48F480B7FEAFQ46657592-F73F384D-0E3D-47BF-9766-AECDF597C451Q51574513-F58FE822-A035-4EFB-BD7A-9DE2A6EAEF3DQ53689031-27C9174B-3B69-4495-8DD9-A85B32D33C55Q57112024-1E7C5E69-2386-4596-96C8-AB0FC4CA8444Q58834940-79710BE8-8E25-443D-AA62-FC2C5F6E7AED
P2860
Immunotherapy with fragmented Mycobacterium tuberculosis cells increases the effectiveness of chemotherapy against a chronical infection in a murine model of tuberculosis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Immunotherapy with fragmented ...... murine model of tuberculosis.
@en
Immunotherapy with fragmented ...... murine model of tuberculosis.
@nl
type
label
Immunotherapy with fragmented ...... murine model of tuberculosis.
@en
Immunotherapy with fragmented ...... murine model of tuberculosis.
@nl
prefLabel
Immunotherapy with fragmented ...... murine model of tuberculosis.
@en
Immunotherapy with fragmented ...... murine model of tuberculosis.
@nl
P2093
P921
P1433
P1476
Immunotherapy with fragmented ...... murine model of tuberculosis.
@en
P2093
Evelyn Guirado
Gustavo Tapia
Isabel Amat
Jorge Díaz
Sergi Gordillo
Vicenç Ausina
Virginia Arcos
P304
P356
10.1016/J.VACCINE.2004.09.008
P407
P577
2005-02-01T00:00:00Z